Received Jan 14, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
Vaccine stored outside recommended conditions and administered to patient/During this time the vaccine was not stored between 2 to 8°C but at 25°C; This non-serious case was reported by a nurse via call center representative and described the occurrence of incorrect storage of drug in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incorrect storage of drug (Verbatim: Vaccine stored outside recommended conditions and administered to patient/During this time the vaccine was not stored between 2 to 8°C but at 25°C). The outcome of the incorrect storage of drug was not applicable. Additional Information: GSK Receipt Date: 12-JAN-2026 8 minutes after reconstitution, administered Shingrix. During this time the vaccine was not stored between 2 to 8 degree C but at 25 degree C. The reporter asked was the vaccine less effective. The batch number was not provided, and we are unable to contact the reporter.